However, this study uniquely demonstrates that dual MCT1 and MCT4 inhibition with syrosingopine was more potent in primary CD138 + MM cells derived from patients with elevated serum LDH levels than those without elevated serum LDH levels. The gene discussed is SLC16A3; the disease is Miyoshi myopathy.